Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
254 mg/m³
DNEL related information
DNEL derivation method:
other: ECETOC technical report No. 86
Overall assessment factor (AF):
6
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
medium hazard (no threshold derived)
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
medium hazard (no threshold derived)
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
medium hazard (no threshold derived)
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:
medium hazard (no threshold derived)

Additional information - workers

Derivation of DNEL-workers

Hazard via inhalation route

Hazard assessment of the substance is based on the most hazardous degradation product, 2 -methylpropanol, since the target substance reacts in use applications and no reliable study is available from the substance itself.

NOAEC from rat subchronic inhalation study of 2 -methylpropanol is used to derive DNEL.

NOAEC = 1000 ppm (3030 mg/m3) for 2-methylpropanol; subchronic, inhalation, rat by Li, A. A. et al. (1999).

Modification of the dose descriptor according to ECHA Guidance R.8 (November 2012) Example B. 1.

Route of exposure (inhalation vs inhalation); bioavailability is assumed to be 100 % in humans and in experimental animals

Corrected inhalatory NOAEC= inhalatory NOAEC * exp. time rat / exp. time worker * ABS rat / ABS human * sRVhuman 8h / wRV

ABS - absorption

sRVhuman - respiratory volume under standard conditions

wRV - respiratory volume light activity for worker

Corrected inhalatory NOAEC= 3 030 mg/m3* (6h/d / 8h/d) * (100/100) * (6,7m3/10m3) =1 523 mg/m3

Assessment factors – Based on ECETOC (2003) technical report No. 86

Intraspecies differences for worker = 3

Exposure duration - subchronic to chronic = 2

Overall AF = 3*2 = 6 

DNEL worker systemic effects by inhalation= 1 523 mg/m3 / 6 = 254 mg/m3

General Population - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
303 mg/m³
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
By inhalation
DNEL related information
DNEL derivation method:
other: ECETOC technical report No. 86
Overall assessment factor (AF):
10
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
medium hazard (no threshold derived)
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
220 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
By inhalation
DNEL related information
DNEL derivation method:
other: ECETOC technical report No. 86
Overall assessment factor (AF):
40
Explanation for the modification of the dose descriptor starting point:
NOAEC from rat subchronic inhalation study of 2-methylpropanol is used to derive this DNEL since no dermal study is available from the substance or from the degradation product.
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
medium hazard (no threshold derived)
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

General Population - Hazard via oral route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
22 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
By inhalation
DNEL related information
DNEL derivation method:
other: ECETOC technical report No. 86
Overall assessment factor (AF):
40
Explanation for the modification of the dose descriptor starting point:
NOAEC from rat subchronic inhalation study of 2-methylpropanol is used to derive this DNEL since no oral study is available from the substance or from the degradation product.
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard for the eyes

Local effects

Hazard assessment conclusion:
medium hazard (no threshold derived)

Additional information - General Population

Derivation of DNEL-general population

Hazard via inhalation route

Hazard assessment of bis(ethylacetoacetato-O1’,O3”) bis(2 -methyl propan-1 -olato)titanium is based on the most hazardous degradation product, 2 -methylpropanol, since the target substance reacts in use applications and no reliable study is available from the substance itself.

NOAEC from rat subchronic inhalation study of 2 -methylpropanol, is used to derive DNEL.

Relevant dose descriptor for the endpoint

NOAEC = 1 000 ppm (3 030 mg/m3) for 2-methylpropanol; subchronic, inhalation, rat by Li, A. A. et al. (1999).

Modification of the dose descriptor according to ECHA Guidance R.8 (November 2012) Example B. 1.

Route of exposure (inhalation vs inhalation); bioavailability is assumed to be 100% in humans and in experimental animals. Exposure time is 6 h/day for rats and for humans.

Corrected inhalatory NOAEC= inhalatory NOAEC * exp. time rat / exp. time general population * ABS rat / ABS human

ABS - absorption

Corrected inhalatory NOAEC= 3 030 mg/m3* (6 h/d / 6 h/d) * (100/100) =3 030 mg/m3

Assessment factors – Based on ECETOC (2003) technical report No. 86

Intraspecies differences for general population = 5

Exposure duration - subchronic to chronic = 2

Overall AF = 5 x 2 = 10

DNEL general population chronic systemic by inhalation route = 3 030 mg/m3 / 10 = 303 mg/m3

 -----------------------

Hazard via oral route

Hazard assessment of bis(ethylacetoacetato-O1’,O3”) bis(2-methyl propan-1-olato)titanium is based on the most hazardous degradation product, 2 -methylpropanol, since the target substance reacts in use applications and no reliable study is available from the substance itself.

NOAEC from rat subchronic inhalation study of2 -methylpropanol, is used to derive DNEL.

Relevant dose descriptor for the endpoint

NOAEC = 1 000 ppm (3 030 mg/m3) for 2 -methylpropanol; subchronic, inhalation, rat by Li, A. A. et al. (1999).

Modification of the dose descriptor according to ECHA Guidance R.8 (November 2012) Example B. 4.

Route of exposure (inhalation vs oral); bioavailability is assumed to be 100% in humans and in experimental animals

Corrected oral NOAEL = inhalatory NOAEC * sRV rat 6h * exp. time rat / exp. time general population * ABS inh-rat / ABS oral-human

ABS - absorption

sRV - standard respiratory volume

Corrected oral NOAEL= 3 030 mg/m3* 0.29 * (6 h/d / 6 h/d) * (100/100) =879 mg/kg bw/day

Assessment factors – Based on ECETOC (2003) technical report No. 86

Allometric scaling = 4

Intraspecies differences for general population = 5

Exposure duration - subchronic to chronic = 2

Overall AF = 4 x 5 x 2 = 40

DNEL general population chronic systemic by oral route = 879 mg/kg bw/day / 40 = 22 mg/kg bw/day

-----------------------

Hazard via dermal route

Hazard assessment of bis(ethylacetoacetato-O1’,O3”) bis(2-methyl propan-1-olato)titanium is based on the most hazardous degradation product, 2 -methylpropanol, since the target substance reacts in use applications and no reliable study is available from the substance itself.

NOAEC from rat subchronic inhalation study of 2 -methylpropanol, is used to derive DNEL.

Relevant dose descriptor for the endpoint

NOAEC = 1 000 ppm (3030 mg/m3) for 2 -methylpropanol; subchronic, inhalation, rat by Li, A. A. et al. (1999).

Modification of the dose descriptor according to ECHA Guidance R.8 (November 2012) Example B. 4.

100 % inhalation absorption regardless of species

10 % dermal absorption regardless of species

Corrected dermal NOAEL = inhalatory NOAEC * sRV rat 6h * exp. time rat / exp. time general population * ABS inh-rat / ABS dermal-human

ABS - absorption

sRV - standard respiratory volume

Corrected dermal NOAEL= 3030 mg/m3* 0.29 * (6 h/d / 6 h/d) * (100/10) = 8787 mg/kg bw/day

Assessment factors – Based on ECETOC (2003) technical report No. 86

Allometric scaling = 4

Intraspecies differences for general population = 5

Exposure duration - subchronic to chronic = 2

Overall AF = 4 x 5 x 2 = 40

DNEL general population chronic systemic by dermal route = 8787 mg/kg bw/day / 40 = 220 mg/kg bw/day